Insider sale notice: Axsome Therapeutics (NASDAQ: AXSM) files Form 144

Rhea-AI Filing Summary

Axsome Therapeutics reports insider Form 144 notice for sales of Class A Common stock by Mark Jacobson. The filing lists securities to be sold on 05/04/2026 described as "Acquired as compensation -- Stock Options" with planned cashless exercise / same-day sale treatment. The excerpt also records completed sales on 02/26/2026 of 15,378 and 20,000 shares.

Key Figures

Planned sale date: 05/04/2026 Prior sale — shares: 15,378 shares Prior sale — shares: 20,000 shares +2 more

5 metrics

Planned sale date 05/04/2026 date listed for securities to be sold (acquired as compensation)

Prior sale — shares 15,378 shares sale recorded on 02/26/2026 by Mark Jacobson

Prior sale — shares 20,000 shares sale recorded on 02/26/2026 by Mark Jacobson

Proceeds shown (example) $2,505,062.36 dollar figure listed alongside 15,378-share sale on 02/26/2026

Proceeds shown (example) $3,221,848 dollar figure listed alongside 20,000-share sale on 02/26/2026

Key Terms

Form 144, cashless exercise / same-day sale, Acquired as compensation -- Stock Options, Class A Common

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

cashless exercise / same-day sale financial

"Compensation -- Cashless exercise / same-day sale"

Acquired as compensation -- Stock Options financial

"Acquired as compensation -- Stock Options"

Class A Common market

"Class A Common | 05/04/2026"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	4517	1010452.9	51439952	05/04/2026	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	05/04/2026	Acquired as compensation -- Stock Options	Issuer			4517	05/04/2026	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Jacobson One World Trade Center 29th Floor New York NY 10007	Class A Common	02/26/2026	15378	2505062.36
Mark Jacobson One World Trade Center 29th Floor New York NY 10007	Class A Common	02/26/2026	20000	3221848

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Axsome Therapeutics (AXSM) Form 144 filed by Mark Jacobson disclose?

It discloses a notice of proposed sale of Class A Common stock by Mark Jacobson. The filing states planned sales on 05/04/2026 via cashless exercise/same-day sale and prior sales on 02/26/2026 of 15,378 and 20,000 shares.

How many shares did Mark Jacobson report selling recently for AXSM?

The filing records sales on 02/26/2026 of 15,378 and 20,000 Class A Common shares. The document shows dollar figures alongside each sale but does not aggregate totals beyond those line items.

What method is used for the proposed AXSM sale in the Form 144?

The proposed sale is described as a "cashless exercise / same-day sale." That indicates options will be exercised and resulting shares sold on the same day, per the filing language on 05/04/2026.

Are the shares being sold by Mark Jacobson compensation-related for AXSM?

Yes. The Form 144 notes the securities were "Acquired as compensation -- Stock Options." The filing ties the planned sale on 05/04/2026 to options received as compensation.

Does the Form 144 state proceeds or transaction counterparties for the AXSM sales?

The excerpt shows dollar amounts next to prior sales but does not identify counterparties. The filing lines include proceeds figures for the 02/26/2026 sales, while buyer identities are not disclosed in the provided text.